1. Home
  2. PVLA vs KIDS Comparison

PVLA vs KIDS Comparison

Compare PVLA & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • KIDS
  • Stock Information
  • Founded
  • PVLA 2015
  • KIDS 2007
  • Country
  • PVLA United States
  • KIDS United States
  • Employees
  • PVLA N/A
  • KIDS N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • KIDS Medical/Dental Instruments
  • Sector
  • PVLA Health Care
  • KIDS Health Care
  • Exchange
  • PVLA Nasdaq
  • KIDS Nasdaq
  • Market Cap
  • PVLA 604.2M
  • KIDS 524.3M
  • IPO Year
  • PVLA N/A
  • KIDS 2017
  • Fundamental
  • Price
  • PVLA $65.78
  • KIDS $18.77
  • Analyst Decision
  • PVLA Strong Buy
  • KIDS Strong Buy
  • Analyst Count
  • PVLA 12
  • KIDS 7
  • Target Price
  • PVLA $66.67
  • KIDS $34.14
  • AVG Volume (30 Days)
  • PVLA 179.9K
  • KIDS 160.3K
  • Earning Date
  • PVLA 11-15-2025
  • KIDS 11-05-2025
  • Dividend Yield
  • PVLA N/A
  • KIDS N/A
  • EPS Growth
  • PVLA N/A
  • KIDS N/A
  • EPS
  • PVLA N/A
  • KIDS N/A
  • Revenue
  • PVLA N/A
  • KIDS $220,733,000.00
  • Revenue This Year
  • PVLA N/A
  • KIDS $19.30
  • Revenue Next Year
  • PVLA N/A
  • KIDS $17.12
  • P/E Ratio
  • PVLA N/A
  • KIDS N/A
  • Revenue Growth
  • PVLA N/A
  • KIDS 26.08
  • 52 Week Low
  • PVLA $11.17
  • KIDS $16.59
  • 52 Week High
  • PVLA $65.80
  • KIDS $32.00
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 70.90
  • KIDS 45.28
  • Support Level
  • PVLA $60.49
  • KIDS $17.85
  • Resistance Level
  • PVLA $65.57
  • KIDS $18.79
  • Average True Range (ATR)
  • PVLA 3.63
  • KIDS 0.77
  • MACD
  • PVLA 0.19
  • KIDS -0.05
  • Stochastic Oscillator
  • PVLA 99.83
  • KIDS 44.75

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Share on Social Networks: